startup

Eisbach

Development of drugs targeting chromatin regulatory mechanisms important for tumors.
  • Chemicals/Pharmaceuticals
  • Seed Stage
  • Retail / E-Commerce
  • B2B
  • 2019
  • 1-10 Employees
  • Found
  • Planegg-Martinsried, DE
  • Login required
  • Eisbach Bio GmbH
  • Bayern

Profile is not claimed et

This profile is created by the Startbase Analyst Team. If you are a team member of this company you can claim the profile in order to make changes to it.

Is this your company? Claim profile
Adrian Schomburg Geschäftsführer
Andreas Ladurner Geschäftsführer

News about Eisbach

Recent mentions of Eisbach in podcasts & videos:

Jobs at Eisbach:

Related companies

High-Tech Gründerfonds
Investor 2005 Bonn High-Tech Gründerfonds HTGF is one of the leading and most active early-stage investors in Germany and Europe.
Startup 2016 Gräfelfing Immunic Therapeutics Clinical-stage biopharmaceutical company developing a range of selective oral immunological therapies.
Startup 2019 München Sinpex
Startup 2017 Planegg mk2 Biotechnologies Develops, produces and researches peptides using a synthesis technology.
Investor 2014 Berlin Rocket Internet Rocket Internet incubates, builds and operationally develops internet-based business models. It provides operational support to its companies and helps them scale internationally.

Other Startups nearby

Startup 2011 Martinsried Dust BioSolutions Dust BioSolutions is a start-up company focusing on industrial applications of biotechnology.
Startup 2010 Martinsried GNA Biosolutions Developing instruments, OEM modules and tests for the ultrafast, molecular biological detection of a wide range of pathogens. The core is a specially developed technology called laser PCR.
Startup 2008 Martinsried ChromoTek Development and commercialization of Nanobody-based reagents.
Startup 2010 Planegg Lindis Biotech Development of Triomab® antibodies - a new class of T-cell activating bispecific antibodies that enable the immune system to transform malignant cancers into treatable and potentially curable diseases.
Startup 2013 Planegg Bind-X Industrial applications in the field of biotechnology.

FYI: English edition available

Hello my friend, have you been stranded on the German edition of Startbase? At least your browser tells us, that you do not speak German - so maybe you would like to switch to the English edition instead?

Go to English edition

FYI: Deutsche Edition verfügbar

Hallo mein Freund, du befindest dich auf der Englischen Edition der Startbase und laut deinem Browser sprichst du eigentlich auch Deutsch. Magst du die Sprache wechseln?

Deutsche Edition öffnen